Anticoccidial Drugs Market Analysis

Anticoccidial Drugs Market Size (2021 to 2030)

The global anticoccidial drugs market is expected to have a growth rate of 3.61% CAGR from 2021 to 2030. As a result, the market is anticipated to grow by USD 1691.94 Million by 2028.

Anticoccidial Drugs Market Share Insights

Based on the Drug type, the ionophore anticoccidials segment had the largest market share of the global anticoccidial drugs market in 2022. Based on animal type, the poultry animal segment had the largest market share of the global anticoccidial drugs market in 2022.

Impact of COVID-19 on the global anticoccidial drugs market

The disease has spread to almost every country globally since the COVID-19 virus outbreak in December 2019, prompting the World Health Organization to declare it a public health emergency. Coccidiosis is a viral disease caused by a single-cell parasite that can only be seen under a microscope.

Market Drivers

YOY growth in the prevalence of coccidiosis and increasing focus on animal health primarily accelerates the global anticoccidial drugs market. The growing number of veterinary hospitals, rise in demand to improve the quality of drugs with different techniques, growing disposable income in urban areas are further helping the global anticoccidial drugs market to grow.

Market Restraints

The need for more skilled persons in manufacturing appropriate drugs with correct dosage forms slowly restricts the global anticoccidial drug market. In addition, the availability of other drugs at a lower cost and fluctuations in the prices of final products due to the less availability of raw materials are expected to limit the growth of the global anticoccidial drugs market.

Anticoccidial Drugs Market - By Drug Type

Antibiotic Anticoccidials

Ionophore Anticoccidials

Chemical Derivative Anticoccidials

Anticoccidial Drugs Market - By Animal Type

Poultry

Swine

Fish

Cattle

Companion Animal

Anticoccidial Drugs Market - By Region

North America

Europe

Asia Pacific

Latin America

Middle East and Africa

Key Market Players

Noteworthy companies in the global anticoccidial drugs market profiled in this report are Bayer Health care, Zoetis, Elanco, Merial, Merck Animal Healthcare, Ceva Santé Animale, Virbac, Boehringer Ingelheim Animal Health, Novartis Animal Healthcare, and Smartvet Inc.

Recent Developments in the Market

In April 2022, Amlan International, a U.S.-based company operating in veterinary healthcare, announced natural alternatives to anticoccidial drugs.

In May 2020, Zoetis showed suckling calves with significant weight gain from implants.

In September 2019, Virbac launched Multimin, which is used for cattle.

In October 2019, Ceva Sante Animale agreed with ProBioGen, the manufacturer, to represent a transformation of poultry vaccines with the help of ProBioGen's proprietary AGE1.CR technology.